Literature DB >> 17612814

Differential course of executive control changes during normal aging.

Friederike H Treitz1, Katrin Heyder, Irene Daum.   

Abstract

Normal aging has been associated with executive control deficits, but it is as yet unclear whether different executive subprocesses are differentially affected during the course of aging. The present study aimed to investigate age effects on a range of executive control subcomponents. Four consecutive age groups (20-30 years, 31-45 years, 46-60 years, 61-75 years), matched on present state IQ and mood, were compared on tasks of strategic memory processing, verbal fluency, reasoning, inhibition, task management, and self-rating of executive abilities. Deficits concerning the suppression of habitual and experimentally induced prepotent response tendencies and the ability to efficiently divide attention were observed in subjects over 60 years of age compared to the younger groups, while memory, verbal fluency, and reasoning were largely unaffected. Results suggest a sharp decline of executive function after age 60 and a differential course of different executive subcomponents across aging, adding further support to a multi-dimensional model of executive function.

Mesh:

Year:  2007        PMID: 17612814     DOI: 10.1080/13825580600678442

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  32 in total

1.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

2.  The neuropsychology of normal aging and preclinical Alzheimer's disease.

Authors:  Richard J Caselli; Dona E C Locke; Amylou C Dueck; David S Knopman; Bryan K Woodruff; Charlene Hoffman-Snyder; Rosa Rademakers; Adam S Fleisher; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2013-03-26       Impact factor: 21.566

Review 3.  How does decisional capacity evolve with normal cognitive aging: systematic review of the literature.

Authors:  Thomas Tannou; Séverine Koeberlé; Régis Aubry; Emmanuel Haffen
Journal:  Eur Geriatr Med       Date:  2019-10-12       Impact factor: 1.710

4.  Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.

Authors:  R J Caselli; A C Dueck; D E C Locke; C R Hoffman-Snyder; B K Woodruff; S Z Rapcsak; E M Reiman
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

5.  Aging and random task switching: the role of endogenous versus exogenous task selection.

Authors:  Christopher P Terry; Martin J Sliwinski
Journal:  Exp Aging Res       Date:  2012       Impact factor: 1.645

6.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

7.  Naturalistic assessment of executive function and everyday multitasking in healthy older adults.

Authors:  Courtney McAlister; Maureen Schmitter-Edgecombe
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2013-04-04

Review 8.  Selective attention in normal and impaired hearing.

Authors:  Barbara G Shinn-Cunningham; Virginia Best
Journal:  Trends Amplif       Date:  2008-10-30

9.  Brain activation during interference resolution in young and older adults: an fMRI study.

Authors:  David C Zhu; Rose T Zacks; Jill M Slade
Journal:  Neuroimage       Date:  2010-01-04       Impact factor: 6.556

10.  Targeting alertness to improve cognition in older adults: A preliminary report of benefits in executive function and skill acquisition.

Authors:  Thomas M Van Vleet; Joseph M DeGutis; Michael M Merzenich; Gregory V Simpson; Ativ Zomet; Sawsan Dabit
Journal:  Cortex       Date:  2016-06-02       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.